Delapril
An overview of the antihypertensive drug Delapril
| Delapril | |
|---|---|
|
|
Delapril is a medication used primarily in the treatment of hypertension (high blood pressure). It belongs to the class of drugs known as angiotensin-converting enzyme inhibitors (ACE inhibitors), which work by relaxing blood vessels and reducing the workload on the heart.
Mechanism of action[edit]
Delapril functions by inhibiting the angiotensin-converting enzyme (ACE), which is responsible for the conversion of angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor, meaning it narrows blood vessels and increases blood pressure. By blocking this conversion, Delapril helps to lower blood pressure and improve blood flow.
Pharmacokinetics[edit]
Delapril is administered orally and is absorbed through the gastrointestinal tract. It is a prodrug, meaning it is metabolized into its active form, delaprilat, in the liver. The drug is then excreted primarily through the kidneys.
Clinical uses[edit]
Delapril is used to manage hypertension and may be prescribed alone or in combination with other antihypertensive agents. It is also used in the treatment of heart failure and to improve survival after a myocardial infarction (heart attack).
Side effects[edit]
Common side effects of Delapril include cough, dizziness, and fatigue. Like other ACE inhibitors, it can cause hyperkalemia (elevated potassium levels) and angioedema (swelling of the deeper layers of the skin). Patients are advised to report any signs of swelling or difficulty breathing to their healthcare provider immediately.
Contraindications[edit]
Delapril is contraindicated in patients with a history of angioedema related to previous ACE inhibitor therapy and in those with renal artery stenosis. It should not be used during pregnancy due to the risk of fetal harm.
Related pages[edit]
-
Delapril
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian